Literature DB >> 20452006

Changes of lipid composition in non-cultured and cultured porcine embryos.

M Romek1, B Gajda, E Krzysztofowicz, Z Smorag.   

Abstract

The objective of the present study was to evaluate the lipid composition of cultured and non-cultured pig embryos during cleavage using histochemical methods. The authors studied pig zygotes as well as 2-to 4-cell embryos, morulae, and blastocysts that were either non-cultured or cultured in NCSU-23 medium. To detect different types of lipids, the authors used the Churukian method with Oil red O, the Sudan black B method, the Cain method with Nile blue sulfate, and the modified osmium tetroxide-ethanol treatment. In the zygotic lipid droplets, diverse classes of unsaturated and saturated lipids were found, with particularly high levels of unsaturated hydrophobic lipids, mainly triglycerides and other esters, free fatty acids, and phospholipids. In the zygotic cytoplasm, the authors observed high levels of fatty acids and phospholipids. The total lipid content remained constant up to the morula stage, decreasing later at the blastocyst stage, but the overall amount of unsaturated lipids declined earlier, at the 2-to 4-cell stage. The amount of free fatty acids and phospholipids decreased during cleavage in both non-cultured and cultured porcine embryos. The main differences between the non-cultured and cultured embryos were the more pronounced reduction in the amount of unsaturated hydrophobic lipids in droplets and the cytoplasmic free fatty acids observed in the cultured morula and the lower content of phospholipids in the cytoplasm of the cultured 2-to 4-cell embryos relative to the non-cultured embryos. The decrease in the unsaturated lipid, free fatty acid, and phospholipid content during in vivo development and the differences in the amount of these types of lipids between developmentally matched cultured and non-cultured pig embryos correlate well with modifications of lipid and carbohydrate metabolism. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20452006     DOI: 10.1016/j.theriogenology.2010.02.010

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Ovarian granulosa cells from women with PCOS express low levels of SARS-CoV-2 receptors and co-factors.

Authors:  Aalaap Naigaonkar; Krutika Patil; Shaini Joseph; Indira Hinduja; Srabani Mukherjee
Journal:  Arch Gynecol Obstet       Date:  2022-04-27       Impact factor: 2.493

2.  The Open Cryotop System Is Effective for the Simultaneous Vitrification of a Large Number of Porcine Embryos at Different Developmental Stages.

Authors:  Alejandro Gonzalez-Plaza; Josep M Cambra; Inmaculada Parrilla; Maria A Gil; Emilio A Martinez; Cristina A Martinez; Cristina Cuello
Journal:  Front Vet Sci       Date:  2022-06-22

3.  Albumin used in human IVF contain different levels of lipids and modify embryo and fetal growth in a mouse model.

Authors:  Deirdre Zander-Fox; Lauren Villarosa; Nicole O McPherson
Journal:  J Assist Reprod Genet       Date:  2021-06-11       Impact factor: 3.357

4.  Cryopreservation of In Vitro-Produced Early-Stage Porcine Embryos in a Closed System.

Authors:  Hongsheng Men; Lee D Spate; Clifton N Murphy; Randall S Prather
Journal:  Biores Open Access       Date:  2015-05-01

5.  The consequences of porcine IVM medium supplementation with follicular fluid become reflected in embryo quality, yield and gene expression patterns.

Authors:  Piotr Pawlak; Ewelina Warzych; Adam Cieslak; Natalia Malyszka; Eliza Maciejewska; Zofia Eliza Madeja; Dorota Lechniak
Journal:  Sci Rep       Date:  2018-10-17       Impact factor: 4.379

6.  Lipid Stores and Lipid Metabolism Associated Gene Expression in Porcine and Bovine Parthenogenetic Embryos Revealed by Fluorescent Staining and RNA-seq.

Authors:  Arkadiusz Kajdasz; Ewelina Warzych; Natalia Derebecka; Zofia E Madeja; Dorota Lechniak; Joanna Wesoly; Piotr Pawlak
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.